Assay kit for Canine Antithrombin receptor (ELISA)
Species reactivity
canine
ELISA type
competitive
Assay sensitivity
1.0ng per ml
Detection range
5.0-100ng per ml
Original name
Canine Antithrombin receptor ELISA kit
Properties
E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays
Test
BlueGen ELISAs supplies other types of Assays as 1.ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED
Reproducibility of the results
Intra-Assay: Coefficient of variability is lower than 10%; Inter-Assay: Coefficient of variability is lower than 15%
Tips
The product Assay kit for Canine Antithrombin receptor (ELISA)is intended to be used for research purposes only. It is not tested for application in diagnostics.
Cross reactivity
There is no indicative cross reactivity between the antigen and its analogues detected during the testing of the product Assay kit for Canine Antithrombin receptor (ELISA)
Product storage
The product Assay kit for Canine Antithrombin receptor (ELISA) should be kept between two and eight degrees Celsius to ensure the retention of the stability and reactivity of the reagents included in the kit.
Kit configuration
1xMicrotiter test plate; 1 vial x Enzyme conjugate; 1 vial x STANDARD A; 1 vial x STANDARD B; 1 vial x STANDARD C; 1 vial x STANDARD D; 1 vial x STANDARD E; 1 vial x STANDARD F; 1 vial x SUBSTRATE A; 1 vial x SUBSTRATE B; 1 vial x Stop solution; 1 vial x Wash solution (100x); 1 vial x Balance solution; 1 x protocol
Description
The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.